Article : Périodique

Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort

J. R. MORGAN ; B. R. SCHACKMAN ; Z. M. WEINSTEIN ; A. Y. WALLEY ; B. P. LINAS |

Dans Drug and Alcohol Dependence (Vol.200, July 2019)

Background and aims: Despite the growing opioid overdose crisis, medication treatment for opioid use disorder remains uncommon. The comparative effectiveness of buprenorphine and naltrexone treatment in reducing overdose and the comparative risk[...]

Plus d'information...

Ajouter au panier